Mismatched Unrelated Donor (MMUD) HCT: Expanding Access for Diverse Populations

Details

Description

This panel discussion will provide insight into the 15-MMUD study that looks at mismatched unrelated donor (MMUD) HCT using PTCy and bone marrow. The results show it is safe and effective, expanding access for diverse populations. The panelists will discuss implications of this study on the BMT and CGT field and how it could impact clinical decision-making on patient treatment.

During this panel discussion, panelists will discuss:

The results of the Access study/15-MMUD study (PTCY and bone marrow)
The ongoing efforts to determine efficacy of PTCY and PBSC
Considerations between haploidentical donors and mismatched unrelated donors
Implications of these studies to the field of BMT and CGT: How these learnings impact clinical decision-making for patients of underserved populations; what barriers to transplant might still exist, despite improving treatment outcomes

Speakers

Steven Devine, MD, Chief Medical Officer, NMDP/Be The Match, Associate Scientific Director, CIBMTR
Gary Simmons, DO, Virginia Commonwealth University Medical Center
Krishna Komanduri, MD, University of Miami